- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02727634
Ultrapower; a Minimally Invasive Tool for Evaluation of Total Cardiac Power
March 26, 2019 updated by: Norwegian University of Science and Technology
Ultrapower, an In-house Developed System for Instantaneous Logging of Ultrasound Based Blood Flow, Blood Pressure and ECG.
The heart is essentially a hydraulic pump which ensures adequate delivery of blood through generating pressure and forward flow of blood.
The energy delivered by the heart is uncommonly measured clinically, and todays gold standard involves placing a plastic catheter into the lung arteries.
The investigators have developed an ultrasound based approach to calculate this energy without the need for catheters through the heart.
This novel approach is called ultrapower.
Ultrapower involves the instantaneous multiplication of the cardiac output and the arterial blood pressure.
The study aims to use the ultrasound based approach to investigate Cardiac Power in the coronary artery bypass graft population.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trondheim, Norway
- Department of Cardiothoracic Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
• coronary artery bypass graft operation
Exclusion Criteria:
- Lack of informed consent
- Previous aortic valve replacement
- Inadequate Doppler signal on transthoracic echocardiography
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Postoperative elective CABG patients
Patients included for coronary artery bypass graft (CABG) surgery, secondary to ischaemic heart disease.
|
The intervention is a comparison between two methods of calculating the heart's energy delivery, cardiac power, measured in watts.
A tertiary measurement is calculation of arterioventricular coupling.
All patients will have cardiac power output calculated through the use of Doppler echocardiography.
The echocardiography based cardiac output will be done through the velocity time integral of the left ventricular outflow tract (LVOT).
This will be compared against total power as measured by our Ultrapower approach which involves instantaneous doppler measurement of cardiac output through LVOT multiplied with simultaneous radial artery pressure.
This and ejection fraction (for calculation of ventriculoarterial coupling) will be recorded at rest in neutral position preoperatively, directly post operatively and the day after operation.
Directly postoperatively the power measurements will also be repeated in Trendelenburg and anti Trendelenburg position.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The hearts energy delivery per second measured in watts (Cardiac Power), using two established methods and the ultrapower method
Time Frame: Immediately preoperatively
|
Measured both as ultrapower and cardiac power output, both measured in watts and method of measurement described in intervention section
|
Immediately preoperatively
|
|
The hearts energy delivery per second measured in watts (Cardiac Power), using two established methods and the ultrapower method
Time Frame: approximately 1 hour post operatively
|
approximately 1 hour post operatively
|
|
|
The hearts energy delivery per second measured in watts (Cardiac Power), using two established methods and the ultrapower method
Time Frame: 1 day after operation
|
1 day after operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Idar Kirkeby-Garstad, md phd, Norwegian University of Science and Technology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
March 17, 2016
First Submitted That Met QC Criteria
March 29, 2016
First Posted (Estimate)
April 4, 2016
Study Record Updates
Last Update Posted (Actual)
March 27, 2019
Last Update Submitted That Met QC Criteria
March 26, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016/49
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Diseases
-
Medical University of GdanskActive, not recruitingCardiac Complications | Sudden Cardiac Arrest | Cardiac Arrest (CA) | Cardiac DiseasesPoland
-
Ostfold University CollegeNot yet recruitingCardiac Arrest | Cardiac Arrhythmia | Cardiac Disease | Cardiac Death
-
Paris Sudden Death Expertise CenterHospices Civils de Lyon; University Hospital, Strasbourg, France; University... and other collaboratorsRecruitingDefibrillators, Implantable | Sudden Cardiac Death Due to Cardiac ArrhythmiaFrance
-
Zoll Medical CorporationCompletedSudden Cardiac Death | Cardiac Event | Cardiac Arrythmias | Left Ventricular DysfunctionFrance
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Getinge...CompletedCardiac Arrest | Sudden Cardiac Death | Out-Of-Hospital Cardiac ArrestNetherlands
-
Charite University, Berlin, GermanyUnknownHeart Failure | Sudden Cardiac Death | Cardiac Resynchronisation TherapyGermany
-
Tampere Heart HospitalTampere University; Tampere University HospitalRecruitingSudden Cardiac Death | Sudden Cardiac Death Due to Cardiac Arrhythmia | Sudden Cardiac Arrest | Coronary Arterial Disease (CAD) | Acute Coronary EventFinland
-
National Taiwan University HospitalEnrolling by invitationOut of Hospital Cardiac Arrest | Inhospital Cardiac ArrestTaiwan
-
Haseki Training and Research HospitalCompletedCardiac Arrest (CA) | Out of Hospital Cardiac ArrestTurkey
-
University of British ColumbiaRecruitingSurgery | Cardiac Event | Cardiac Disease | Cardiac Complication | Cardiac Valve Disease | Surgery-ComplicationsCanada
Clinical Trials on Comparison cardiac power and cardiac power output at different time points in the perioperative period
-
University Tunis El ManarCompleted
-
Oregon Health and Science UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Center for Advancing...Active, not recruitingObesity | Cardiovascular Risk Factor | Circadian DysregulationUnited States
-
Vanderbilt University Medical CenterUMC UtrechtCompleted